주요 콘텐츠로 건너뛰기

귀하의 브라우저가 완벽하게 지원되지 않습니다. 옵션이 있는 경우 최신 버전으로 업그레이드하거나 Mozilla Firefox, Microsoft Edge, Google Chrome 또는 Safari 14 이상을 사용하세요. 가능하지 않거나 지원이 필요한 경우 피드백을 보내주세요.

이 새로운 경험에 대한 귀하의 의견에 감사드립니다.의견을 말씀해 주세요새 탭/창에서 열기

Elsevier
엘스비어와 함께 출판

Evan Anderson

EA

Evan Anderson

Moderna, USA

Talk Title: RSV Prevention in Adults

Evan J. Anderson is the Executive Director, Infectious Disease Epidemiology, at Moderna. He graduated summa cum laude from Wheaton College, IL after which he pursued his medical degree at the University of Chicago Pritzker School of Medicine. He remained at the University of Chicago for residency in both internal medicine and pediatrics. Subsequently he completed a combined adult and pediatric infectious diseases fellowship at Northwestern Memorial and Children’s Memorial Hospitals in Chicago. He is board certified in internal medicine, adult infectious diseases, pediatrics and pediatric infectious diseases and split his clinical care between adults and children. He moved from Northwestern to Emory University in 2012. He served as the lead investigator in Georgia for influenza, RSV, and COVID-19 surveillance for the CDC-funded Emerging Infections Program. He was one of the multiple PIs of the Emory University Vaccine and Treatment Evaluation Unit (VTEU) and has been intricately involved with COVID-19 vaccine clinical trials in adults and children. While at Emory University School of Medicine, he rose to the rank of a full Professor of Pediatrics and Medicine. In 2023, he transitioned from Emory to a new role leading the Infectious Disease Epidemiology group at Moderna. He has over 250 total publications with particular interest in rotavirus, RSV, influenza, COVID-19, vaccine clinical trials, immunology, and epidemiology.